Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 134,094 More Arrow 154,525 Less Arrow 33,878
Financial expenses 105,520 Less Arrow 48,639 Less Arrow 1,219
Earnings before taxes -830,812 More Arrow -609,979 More Arrow -548,130
EBITDA -778,671 More Arrow -588,588 More Arrow -546,978
Total assets 1,018,041 More Arrow 1,687,406 Less Arrow 1,012,808
Current assets 855,151 More Arrow 1,604,704 Less Arrow 942,342
Current liabilities 320,988 Less Arrow 264,714 Less Arrow 171,219
Equity capital -167,876 More Arrow 602,911 More Arrow 757,573
- share capital 55,034 Equal arrow 55,034 Less Arrow 46,335
Employees (average) 159 Less Arrow 144 Less Arrow 116

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency -16.5% More Arrow 35.7% More Arrow 74.8%
Turnover per employee 843 More Arrow 1,073 Less Arrow 292
Profit as a percentage of turnover -619.6% More Arrow -394.7% Less Arrow -1618.0%
Return on assets (ROA) -71.2% More Arrow -33.3% Less Arrow -54.0%
Current ratio 266.4% More Arrow 606.2% Less Arrow 550.4%
Return on equity (ROE) 494.9% Less Arrow -101.2% More Arrow -72.4%
Change turnover -20,431 More Arrow 120,647 Less Arrow 27,780
Change turnover % -13% More Arrow 356% More Arrow 456%
Chg. No. of employees 15 More Arrow 28 More Arrow 34
Chg. No. of employees % 10% More Arrow 24% More Arrow 41%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.